257 related articles for article (PubMed ID: 37452329)
1. Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada.
Wissing MD; O'Flaherty A; Dragomir A; Tanguay S; Kassouf W; Aprikian AG
BMC Urol; 2023 Jul; 23(1):119. PubMed ID: 37452329
[TBL] [Abstract][Full Text] [Related]
2. The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada.
Wissing MD; O'Flaherty A; Dragomir A; Tanguay S; Kassouf W; Aprikian AG
Clin Genitourin Cancer; 2021 Aug; 19(4):371-371.e9. PubMed ID: 33676834
[TBL] [Abstract][Full Text] [Related]
3. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term survival has improved after radical cystectomy for bladder cancer in Québec during the years 2000-2015.
Wissing MD; Santos F; Zakaria AS; O'Flaherty A; Tanguay S; Kassouf W; Aprikian AG
J Surg Oncol; 2019 Jun; 119(8):1135-1144. PubMed ID: 30919984
[TBL] [Abstract][Full Text] [Related]
5. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
[TBL] [Abstract][Full Text] [Related]
6. Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
Hinata N; Hussein AA; George S; Trump DL; Levine EG; Omar K; Dasgupta P; Khan MS; Hosseini A; Wiklund P; Guru KA
BJU Int; 2017 Apr; 119(4):605-611. PubMed ID: 27743481
[TBL] [Abstract][Full Text] [Related]
7. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative use of single dose of nonsteroidal anti-inflammatory drugs was not associated with cancer recurrence and mortality after bladder cancer surgery: a retrospective study.
Mao S; Wu Y; Wang R; Guo Y; Yuan J; Ma W; Zhang W; Zhang J; Yan Y; Yao X
Ann Palliat Med; 2020 Jan; 9(1):8-18. PubMed ID: 32005058
[TBL] [Abstract][Full Text] [Related]
9. High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec.
Santos F; Zakaria AS; Kassouf W; Tanguay S; Aprikian A
World J Urol; 2015 Sep; 33(9):1323-30. PubMed ID: 25471670
[TBL] [Abstract][Full Text] [Related]
10. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
[TBL] [Abstract][Full Text] [Related]
11. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
[TBL] [Abstract][Full Text] [Related]
12. Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases.
Mitra AP; Cai J; Miranda G; Bhanvadia S; Quinn DI; Schuckman AK; Djaladat H; Daneshmand S
J Urol; 2022 Feb; 207(2):302-313. PubMed ID: 34994657
[TBL] [Abstract][Full Text] [Related]
13. Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database.
Fairey AS; Kassouf W; Aprikian AG; Chin JL; Izawa JI; Fradet Y; Lacombe L; Rendon RA; Bell D; Cagiannos I; Drachenberg DE; Lattouf JB; Estey EP
Urol Oncol; 2012; 30(6):825-32. PubMed ID: 21889368
[TBL] [Abstract][Full Text] [Related]
14. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Malek R; Kübler H; Stenzl A; Gakis G
Urol Oncol; 2018 Feb; 36(2):43-53. PubMed ID: 29102254
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: A matched cohort analysis.
Murthy PB; Lone Z; Corrigan D; Campbell R; Munoz-Lopez C; Caveney M; Gerber D; Ericson KJ; Thomas L; Zhang JH; Kaouk J; Weight C; Berglund R; Haber GP; Lee BH
Urol Oncol; 2022 Jan; 40(1):10.e13-10.e19. PubMed ID: 34400070
[TBL] [Abstract][Full Text] [Related]
17. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
Patel MI; Bang A; Gillatt D; Smith DP
BJU Int; 2015 Oct; 116 Suppl 3():18-25. PubMed ID: 26334934
[TBL] [Abstract][Full Text] [Related]
18. Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
Westhofen T; Eismann L; Buchner A; Schlenker B; Giessen-Jung C; Becker A; Stief CG; Kretschmer A
Eur Urol Focus; 2022 Nov; 8(6):1659-1665. PubMed ID: 35184991
[TBL] [Abstract][Full Text] [Related]
19. The role of radical cystectomy in patients with clinical T4b bladder cancer.
Black PC; Dinney CP; Brown GA; Kassouf W; Siefker-Radtke AO; Munsell MF; Grossman HB; Kamat AM
Urol Oncol; 2011; 29(2):157-61. PubMed ID: 20456984
[TBL] [Abstract][Full Text] [Related]
20. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A
Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
